Creative Planning’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,931
Closed -$355K 2166
2021
Q2
$355K Sell
1,931
-1,410
-42% -$259K ﹤0.01% 1470
2021
Q1
$511K Sell
3,341
-10,053
-75% -$1.54M ﹤0.01% 1403
2020
Q4
$2.09M Buy
13,394
+324
+2% +$50.6K ﹤0.01% 648
2020
Q3
$1.5M Buy
13,070
+813
+7% +$93K ﹤0.01% 660
2020
Q2
$1.38M Sell
12,257
-713
-5% -$80K ﹤0.01% 626
2020
Q1
$1.17M Buy
12,970
+283
+2% +$25.4K ﹤0.01% 585
2019
Q4
$1.37M Buy
12,687
+158
+1% +$17.1K ﹤0.01% 653
2019
Q3
$1.23M Buy
12,529
+161
+1% +$15.8K ﹤0.01% 665
2019
Q2
$1.62M Sell
12,368
-70
-0.6% -$9.17K 0.01% 561
2019
Q1
$1.68M Buy
12,438
+19
+0.2% +$2.57K 0.01% 521
2018
Q4
$1.21M Sell
12,419
-3,110
-20% -$303K 0.01% 600
2018
Q3
$2.16M Sell
15,529
-859
-5% -$119K 0.01% 459
2018
Q2
$2.04M Sell
16,388
-12,629
-44% -$1.57M 0.01% 466
2018
Q1
$3.23M Buy
29,017
+1,244
+4% +$139K 0.01% 342
2017
Q4
$3.32M Buy
27,773
+11,642
+72% +$1.39M 0.01% 332
2017
Q3
$2.26M Sell
16,131
-4,818
-23% -$676K 0.01% 423
2017
Q2
$2.55M Buy
20,949
+3,610
+21% +$439K 0.01% 363
2017
Q1
$2.1M Buy
17,339
+147
+0.9% +$17.8K 0.01% 407
2016
Q4
$2.1M Sell
17,192
-1,607
-9% -$197K 0.01% 390
2016
Q3
$2.3M Sell
18,799
-3,838
-17% -$470K 0.01% 348
2016
Q2
$2.64M Buy
22,637
+985
+5% +$115K 0.02% 278
2016
Q1
$3.01M Buy
21,652
+6,424
+42% +$894K 0.02% 238
2015
Q4
$2.91M Buy
15,228
+10,849
+248% +$2.07M 0.02% 238
2015
Q3
$685K Buy
+4,379
New +$685K 0.01% 611
2015
Q2
Sell
-3,767
Closed -$653K 3225
2015
Q1
$653K Buy
3,767
+270
+8% +$46.8K 0.01% 619
2014
Q4
$647K Buy
3,497
+117
+3% +$21.6K 0.01% 602
2014
Q3
$560K Buy
3,380
+651
+24% +$108K 0.01% 613
2014
Q2
$426K Sell
2,729
-3,694
-58% -$577K 0.01% 704
2014
Q1
$977K Buy
6,423
+47
+0.7% +$7.15K 0.01% 376
2013
Q4
$847K Sell
6,376
-737
-10% -$97.9K 0.01% 353
2013
Q3
$826K Sell
7,113
-2,020
-22% -$235K 0.02% 308
2013
Q2
$842K Buy
+9,133
New +$842K 0.02% 272